Robyn Strosaker, MD, FAAP, is a physician in the Division of General Pediatrics and Adolescent Medicine and Medical Director, Inpatient Services at University Hospitals Rainbow Babies & Children's Hospital. She is Associate Professor, Pediatrics, Case Western Reserve University School of Medicine.
Dr. Strosaker is board certified in pediatrics. Her special interests include general pediatrics, autism and pediatric hospital medicine. She was named to the UH Rainbow Babies & Children's Hospital staff in 2004.
She is a cum laude graduate of Case Western Reserve University with a bachelor’s degree in biochemical engineering and Case Western Reserve University School of Medicine. As a medical student she was elected to Alpha Omega Alpha Honor Medical Society. She completed her residency in pediatrics at UH Rainbow Babies & Children's Hospital, serving as Chief Resident in her final year of training.
Dr. Strosaker is a frequent speaker on topics related to resident education at national medical education conferences. She is a Fellow of the American Academy of Pediatrics and a member of the American College of Physician Executives.
Honors and Recognition
Fellow, American Academy of Pediatrics
Rainbow Babies & Children's Foundation Margaret B. Marting Trustee Award for Clinical Excellence, 2013
Alpha Omega Alpha Honor Medical Society
American Board of Pediatrics - Pediatrics
Education & Training
1995, Case Western Reserve University
Medical / Professional School(s)
2000, Case Western Reserve University School of Medicine
2001, Pediatrics - University Hospitals of Cleveland
2003, Pediatrics - University Hospitals of Cleveland
2004, Pediatrics/Chief Resident - University Hospitals of Cleveland
General Academic Pediatrics, Autism, Pediatric Hospital Medicine, Pediatric Clinical Operations
UH Rainbow Babies and Children's Hospital
Department of Pediatrics-General Pediatrics and Adolescent Medicine
11100 Euclid Ave
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
For calendar year 2012, Robyn Strosaker, MD did not disclose any Outside Relationships with Industry.